|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 9, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00331.2002
Submitted on August 7, 2002
Accepted on October 3, 2002
1 Department of Pharmacology and Toxicology, and Cancer Research Laboratories, Queen's University, Kingston, Ontario, Canada
* To whom correspondence should be addressed. E-mail: coles{at}post.queensu.ca.
Multidrug Resistance Protein 3 (MRP3) is an ATP-dependent transporter of 17ß-estradiol 17ß(D-glucuronide)(E217ßG), leukotriene C4 (LTC4), methotrexate, and bile salts taurocholate and glycocholate. In the present study, the role of a highly conserved Trp residue at position 1242 on MRP3 transport function was examined by expressing wild-type MRP3 and Ala, Cys, Phe, Tyr and Pro substituted mutants in HEK293T cells. Four MRP3-Trp1242 mutants showed significantly increased E217ßG uptake whereas transport by the Pro mutant was undetectable. Similarly, the Pro mutant did not transport LTC4. By comparison, LTC4 transport by the Ala, Cys, Phe and Tyr mutants was reduced by ~35%. The Ala, Cys, Phe, and Tyr mutants all showed greatly reduced methotrexate and leucovorin transport, except the Tyr mutant which transported leucovorin at levels comparable to wild-type MRP3. In contrast, the MRP3-Trp1242 substitutions did not affect taurocholate transport, or taurocholate and glycocholate inhibition of E217ßG uptake. Thus, Trp1242 substitutions markedly alter the substrate specificity of MRP3, but leave bile salt binding and transport intact.
This article has been cited by other articles:
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |